173 related articles for article (PubMed ID: 11442143)
1. On the association between valproate and polycystic ovary syndrome.
Genton P; Bauer J; Duncan S; Taylor AE; Balen AH; Eberle A; Pedersen B; Salas-Puig X; Sauer MV
Epilepsia; 2001 Mar; 42(3):295-304. PubMed ID: 11442143
[TBL] [Abstract][Full Text] [Related]
2. Hormone profiles in young adults with epilepsy treated with sodium valproate or lamotrigine monotherapy.
Stephen LJ; Kwan P; Shapiro D; Dominiczak M; Brodie MJ
Epilepsia; 2001 Aug; 42(8):1002-6. PubMed ID: 11554885
[TBL] [Abstract][Full Text] [Related]
3. A meta-analysis of polycystic ovary syndrome in women taking valproate for epilepsy.
Hu X; Wang J; Dong W; Fang Q; Hu L; Liu C
Epilepsy Res; 2011 Nov; 97(1-2):73-82. PubMed ID: 21820873
[TBL] [Abstract][Full Text] [Related]
4. Evaluate the effects of antiepileptic drugs on reproductive endocrine system in newly diagnosed female epileptic patients receiving either Valproate or Lamotrigine monotherapy: A prospective study.
Sidhu HS; Srinivasa R; Sadhotra A
Epilepsy Res; 2018 Jan; 139():20-27. PubMed ID: 29144993
[TBL] [Abstract][Full Text] [Related]
5. Polycystic ovarian syndrome in women with epilepsy: a review.
Duncan S
Epilepsia; 2001; 42 Suppl 3():60-5. PubMed ID: 11520327
[TBL] [Abstract][Full Text] [Related]
6. Polycystic ovaries, obesity and insulin resistance in women with epilepsy. A comparative study of carbamazepine and valproic acid in 105 women.
Luef G; Abraham I; Haslinger M; Trinka E; Seppi K; Unterberger I; Alge A; Windisch J; Lechleitner M; Bauer G
J Neurol; 2002 Jul; 249(7):835-41. PubMed ID: 12140666
[TBL] [Abstract][Full Text] [Related]
7. Valproate and the polycystic ovarian syndrome: final thoughts.
Herzog AG; Schachter SC
Epilepsia; 2001 Mar; 42(3):311-5. PubMed ID: 11442145
[No Abstract] [Full Text] [Related]
8. Valproate, lamotrigine, and insulin-mediated risks in women with epilepsy.
Isojärvi JI; Rättyä J; Myllylä VV; Knip M; Koivunen R; Pakarinen AJ; Tekay A; Tapanainen JS
Ann Neurol; 1998 Apr; 43(4):446-51. PubMed ID: 9546324
[TBL] [Abstract][Full Text] [Related]
9. Polycystic ovary syndrome in women using valproate: a review.
Bilo L; Meo R
Gynecol Endocrinol; 2008 Oct; 24(10):562-70. PubMed ID: 19012099
[TBL] [Abstract][Full Text] [Related]
10. Valproate-Induced Polycystic Ovary Syndrome in a Girl with Epilepsy: A Case Study.
Kawakami Y; Fujii S; Ishikawa G; Sekiguchi A; Nakai A; Takase M
J Nippon Med Sch; 2018; 85(5):287-290. PubMed ID: 30464147
[TBL] [Abstract][Full Text] [Related]
11. Hyperandrogenism, postprandial hyperinsulinism and the risk of PCOS in a cross sectional study of women with epilepsy treated with valproate.
Luef G; Abraham I; Trinka E; Alge A; Windisch J; Daxenbichler G; Unterberger I; Seppi K; Lechleitner M; Krämer G; Bauer G
Epilepsy Res; 2002 Jan; 48(1-2):91-102. PubMed ID: 11823113
[TBL] [Abstract][Full Text] [Related]
12. On the association between valproate and polycystic ovary syndrome: a response and an alternative view.
Isojärvi JI; Taubøll E; Tapanainen JS; Pakarinen AJ; Laatikainen TJ; Knip M; Myllylä VV
Epilepsia; 2001 Mar; 42(3):305-10. PubMed ID: 11442144
[No Abstract] [Full Text] [Related]
13. Valproate, hyperandrogenism, and polycystic ovaries: a report of 3 cases.
Isojarvi JI; Tapanainen JS
Arch Neurol; 2000 Jul; 57(7):1064-8. PubMed ID: 10891991
[TBL] [Abstract][Full Text] [Related]
14. Obesity and endocrine disorders in women taking valproate for epilepsy.
Isojärvi JI; Laatikainen TJ; Knip M; Pakarinen AJ; Juntunen KT; Myllylä VV
Ann Neurol; 1996 May; 39(5):579-84. PubMed ID: 8619542
[TBL] [Abstract][Full Text] [Related]
15. Polycystic ovary syndrome and epilepsy--a gynaecological perspective.
Polson DW
Seizure; 2003 Sep; 12(6):397-402. PubMed ID: 12915086
[TBL] [Abstract][Full Text] [Related]
16. Seizure type, antiepileptic drugs, and reproductive endocrine dysfunction in Indian women with epilepsy: a cross-sectional study.
Sahota P; Prabhakar S; Kharbanda PS; Bhansali A; Jain V; Das CP; Modi M
Epilepsia; 2008 Dec; 49(12):2069-77. PubMed ID: 18503558
[TBL] [Abstract][Full Text] [Related]
17. Long-term reproductive endocrine health in young women with epilepsy during puberty.
Mikkonen K; Vainionpää LK; Pakarinen AJ; Knip M; Järvelä IY; Tapanainen JS; Isojärvi JI
Neurology; 2004 Feb; 62(3):445-50. PubMed ID: 14872028
[TBL] [Abstract][Full Text] [Related]
18. Sodium valproate, hyperandrogenism and altered ovarian function in Indian women with epilepsy: a prospective study.
Prabhakar S; Sahota P; Kharbanda PS; Siali R; Jain V; Lal V; Khurana D
Epilepsia; 2007 Jul; 48(7):1371-7. PubMed ID: 17441994
[TBL] [Abstract][Full Text] [Related]
19. [Characteristics of women with epilepsy who developed polycystic ovary syndrome owing to the therapy with valproate sodium].
Minagawa K; Watanabe T; Oyanagi R
No To Hattatsu; 2013 Jul; 45(4):304-8. PubMed ID: 23951943
[TBL] [Abstract][Full Text] [Related]
20. [Remission of polycystic ovary syndrome associated with valproic acid in an epileptic female].
Ribacoba-Montero R; Martínez-Faedo C; Díaz-Díaz C; Salas-Puig J
Rev Neurol; 2003 Apr 1-15; 36(7):639-42. PubMed ID: 12666045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
